FDA approves use of biosimilar insulin as automatic substitute for costly brand-name
CBSN
U.S. regulators took action Wednesday that should make it easier to get a cheaper near-copy of a brand-name insulin at the drugstore.
Doctors must now prescribe what's called a biosimilar drug, or OK its use as a substitution for a more expensive brand-name insulin. The Food and Drug Administration has given its approval to Semglee, the first biosimilar cleared as a substitute for Lantus, a widely used fast-acting insulin.More Related News
Ashley White received her earliest combat action badge from the United States Army soon after the first lieutenant arrived in Afghanistan. The silver military award, recognizing soldiers who've been personally engaged by an attacker during conflict, was considered an achievement in and of itself as well as an affirming rite of passage for the newly deployed. White had earned it for using her own body to shield a group of civilian women and children from gunfire that broke out in the midst of her third mission in Kandahar province. All of them survived. She never mentioned the badge to anyone in her battalion.